An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE

NCT04912856 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision; not a safety decision

Conditions

Epilepsy
Epilepsy in Children
Epilepsy; Seizure
Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Epileptic Syndromes

Interventions

DRUG: XEN496

Sponsor

Xenon Pharmaceuticals Inc.